Development of a model to predict vestibular schwannoma growth: An opportunity to introduce new wait and scan strategies
Open Access
- 22 October 2020
- journal article
- research article
- Published by Wiley in Clinical Otolaryngology
- Vol. 46 (1) , 273-283
Abstract
Objectives: To develop a prediction model to predict vestibular schwannoma (VS) growth for patients in a wait and scan (W&S) strategy.Design: Retrospective cohort study.Setting: Tertiary hospital (Radboud university medical center, Nijmegen, the Netherlands).Participants: Patients with unilateral VS, entering a W&S strategy and at least one follow‐up MRI available. Data on demographics, symptoms, audiometry and MRI characteristics at time of diagnosis were collected from medical records.Main outcome measures: Following multiple imputation, a multivariable Cox regression model was used to select variables, using VS growth (≥2 mm) as outcome. Decision curve analyses (DCA) were performed to compare the model to the current strategy.Results: Of 1217 analysed VS patients, 653 (53.7%) showed growth during follow‐up. Balance complaints (HR 1.57 (95% CI: 1.31‐1.88)) and tinnitus complaints in the affected ear (HR 1.36 (95% CI: 1.15‐1.61)), Koos grade (Koos 1 is reference, Koos 2 HR 1.03 (95% CI: 0.80‐1.31), Koos 3 HR 1.55 (95% CI: 1.16‐2.06), Koos 4 HR 2.18 (95% CI: 1.60‐2.96)), time since onset of symptoms (IQR HR 0.83 (95% CI: 0.77‐0.88) and intrameatal diameter on MRI (IQR HR 1.67 (95% CI: 1.42‐1.96)) were selected as significant predictors. The model's discrimination (Harrell's C) was 0.69 (95% CI: 0.67‐0.71), and calibration was good. DCA showed that the model has a higher net benefit than the current strategy for probabilities of VS growth of >12%, 15% and 21% for the first consecutive 3 years, respectively.Conclusions: Patients with balance and tinnitus complaints, a higher Koos grade, short duration of symptoms and a larger intrameatal diameter at time of diagnosis have a higher probability of future VS growth. After external validation, this model may be used to inform patients about their prognosis, individualise the W&S strategy and improve (cost‐)effectiveness.Keywords
Funding Information
- ZonMw (837002523)
This publication has 39 references indexed in Scilit:
- Management of Large and Giant Vestibular SchwannomasJournal of Neurological Surgery Part B: Skull Base, 2011
- Expectant Management of Vestibular Schwannoma: A Retrospective Multivariate Analysis of Tumor Growth and OutcomeJournal of Neurological Surgery Part B: Skull Base, 2011
- Predictors of Volumetric Growth and Auditory Deterioration in Vestibular Schwannomas Followed in a Wait and Scan PolicyOtology & Neurotology, 2011
- Vestibular schwannoma: role of conservative managementThe Journal of Laryngology & Otology, 2009
- Conservative Treatment of Vestibular SchwannomaOtology & Neurotology, 2009
- Clinical, Radiographic, and Audiometric Predictors in Conservative Management of Vestibular SchwannomaOtology & Neurotology, 2009
- Vestibular SchwannomaOtology & Neurotology, 2008
- The Natural History of Vestibular SchwannomaOtology & Neurotology, 2006
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 2004
- Determinants of tumor size and growth in vestibular schwannomasJournal of Neurosurgery, 2001